Biomarkers for Tuberous Sclerosis Complex (BioTuScCom) (TuScCom)
Biomarkers for Tuberous Sclerosis Complex: An International Multicenter Observational Longitudinal Protocol
Sponsor: CENTOGENE GmbH Rostock
Terminated
Study no longer pursued.
Other terminated trials from CENTOGENE GmbH Rostock
This observational or N/A phase trial investigates Cardiac Rhabdomyoma and Cortical Dysplasia and is currently terminated or withdrawn. CENTOGENE GmbH Rostock leads this study, which shows 24 recorded versions since 2018 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
24 versions recorded-
Sep 2025 — Present [monthly]
Terminated
-
Sep 2024 — Sep 2025 [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Mar 2023 — Jul 2024 [monthly]
Terminated
Status: Active Not Recruiting → Terminated
-
Apr 2022 — Mar 2023 [monthly]
Active Not Recruiting
▶ Show 19 earlier versions
-
Dec 2021 — Apr 2022 [monthly]
Active Not Recruiting
-
Jun 2021 — Dec 2021 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
May 2021 — Jun 2021 [monthly]
Recruiting
-
Apr 2021 — May 2021 [monthly]
Recruiting
-
Jan 2021 — Apr 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Aug 2020 — Nov 2020 [monthly]
Recruiting
-
May 2020 — Aug 2020 [monthly]
Recruiting
-
Apr 2020 — May 2020 [monthly]
Recruiting
-
Jun 2019 — Apr 2020 [monthly]
Recruiting
-
May 2019 — Jun 2019 [monthly]
Recruiting
-
Apr 2019 — May 2019 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Mar 2019 — Apr 2019 [monthly]
Not Yet Recruiting
Status: Recruiting → Not Yet Recruiting
-
Aug 2018 — Mar 2019 [monthly]
Recruiting
-
Jun 2018 — Aug 2018 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- CENTOGENE GmbH Rostock
For direct contact, visit the study record on ClinicalTrials.gov .